xml version="1.0" encoding="utf-8" ?   Form 8-K   

   false 0000860730        0000860730   2020-02-11 2020-02-11      

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

WASHINGTON, D.C. 20549 

FORM 8-K 

CURRENT REPORT 

PURSUANT TO SECTION 13 OR 15(d) 

OF THE SECURITIES EXCHANGE ACT OF 1934 

Date of Report (Date of earliest event reported): February 11, 2020 

HCA Healthcare, Inc. 

(Exact Name of Registrant as Specified in its Charter) 

  [DATA_TABLE_REMOVED] [DATA_TABLE_REMOVED] 

(615) 344-9551 

(Registrant’s Telephone Number, Including Area Code) 

Not Applicable 

(Former Name or Former Address, if Changed Since Last Report) 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 

    ☐  

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 

    ☐  

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

    ☐  

 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

    ☐  

 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

Securities registered pursuant to Section 12(b) of the Act: [DATA_TABLE_REMOVED] 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 

Emerging growth company ☐ 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 

 Item 8.01.  

Other Events.   

On February 11, 2020, HCA Healthcare, Inc. (the “Company”) issued a press release (the “Press Release”) announcing the commencement of its proposed public offering by its subsidiary HCA Inc. of $1,000,000,000 aggregate principal amount of senior unsecured notes (the “Offering”). The text of the Press Release is set forth as Exhibit 99.1 and is incorporated herein by reference. In connection with the Offering, the Company is disclosing certain information, some of which updates information disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018 (the “Disclosure”). The text of the Disclosure is set forth as Exhibit 99.2 and is incorporated herein by reference.  

 Item 9.01  

Financial Statements and Exhibits.   

(d) Exhibits:  [DATA_TABLE_REMOVED] 

SIGNATURES  

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.  

HCA HEALTHCARE, INC. (Registrant)    

By:      

/s/ John M. Franck II    

John M. Franck II    

Vice President – Legal and Corporate Secretary      

Date: February 11, 2020